Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan M Lund

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Journal of Inherited Metabolic Disease|May 31, 2018
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trialLine Borgwardt, Nathalie Guffon, Yasmina Amraoui, et al.
Pediatric Research|July 22, 2006
Variations in IBD (ACAD8) in children with elevated C4-carnitine detected by tandem mass spectrometry newborn screeningChristina B Pedersen, Claus Bischoff, Ernst Christensen, et al.
Journal of Inherited Metabolic Disease|December 23, 2015
Impact of age at onset and newborn screening on outcome in organic aciduriasJana Heringer, Vassili Valayannopoulos, Allan M Lund, et al.
Journal of Inherited Metabolic Disease|January 14, 2018
Correction to: Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disordersRoland Posset, Angeles Garcia-Cazorla, Vassili Valayannopoulos, et al.
Journal of Inherited Metabolic Disease|April 24, 2016
Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disordersRoland Posset, Angeles Garcia-Cazorla, Vassili Valayannopoulos, et al.
Journal of Inherited Metabolic Disease|December 14, 2017
Correction to: Impact of age at onset and newborn screening on outcome in organic aciduriasJana Heringer, Vassili Valayannopoulos, Allan M Lund, et al.
Human Mutation|January 14, 2014
Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT geneSaadet Mercimek-Mahmutoglu, Joseph Ndika, Warsha Kanhai, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 14, 2012
Mutation-based growth charts for SEDC and other COL2A1 related dysplasiasPaulien A Terhal, Paula van Dommelen, Martine Le Merrer, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Disease Outcomes in Boys with <i>ABCD1</i> Variants Identified by Newborn Screening for X-ALDCecilie S Videbaek, Danielle Hj Kim, Hannah S Hart, et al.
Plos One|November 16, 2022
Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experienceGrigoris Effraimidis, Åse Krogh Rasmussen, Morten Dunoe, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Journal of Inherited Metabolic Disease|May 31, 2018
Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trialLine Borgwardt, Nathalie Guffon, Yasmina Amraoui, et al.
Pediatric Research|July 22, 2006
Variations in IBD (ACAD8) in children with elevated C4-carnitine detected by tandem mass spectrometry newborn screeningChristina B Pedersen, Claus Bischoff, Ernst Christensen, et al.
Journal of Inherited Metabolic Disease|December 23, 2015
Impact of age at onset and newborn screening on outcome in organic aciduriasJana Heringer, Vassili Valayannopoulos, Allan M Lund, et al.
Journal of Inherited Metabolic Disease|January 14, 2018
Correction to: Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disordersRoland Posset, Angeles Garcia-Cazorla, Vassili Valayannopoulos, et al.
Journal of Inherited Metabolic Disease|April 24, 2016
Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disordersRoland Posset, Angeles Garcia-Cazorla, Vassili Valayannopoulos, et al.
Journal of Inherited Metabolic Disease|December 14, 2017
Correction to: Impact of age at onset and newborn screening on outcome in organic aciduriasJana Heringer, Vassili Valayannopoulos, Allan M Lund, et al.
Human Mutation|January 14, 2014
Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT geneSaadet Mercimek-Mahmutoglu, Joseph Ndika, Warsha Kanhai, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|July 14, 2012
Mutation-based growth charts for SEDC and other COL2A1 related dysplasiasPaulien A Terhal, Paula van Dommelen, Martine Le Merrer, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Disease Outcomes in Boys with <i>ABCD1</i> Variants Identified by Newborn Screening for X-ALDCecilie S Videbaek, Danielle Hj Kim, Hannah S Hart, et al.
Plos One|November 16, 2022
Systematic cascade screening in the Danish Fabry Disease Centre: 20 years of a national single-centre experienceGrigoris Effraimidis, Åse Krogh Rasmussen, Morten Dunoe, et al.
Pageof 8